Skip to main content
Clinical Trials/NCT03783858
NCT03783858CompletedNot Applicable

Image Collection of Normal Eyes on the Optos P200TE for Development of an EU Reference Database

Optos, PLC5 sites in 1 country356 target enrollmentStarted: May 30, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Optos, PLC
Enrollment
356
Locations
5
Primary Endpoint
Retinal thickness

Study Overview

Brief Summary

This study is designed to collect in-tissue OCT scans on the Optos P200TE on normal healthy eyes to develop a EU reference database

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
22 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Subject 22 years of age or older on the date of informed consent
  • •Subject able to understand the written informed consent and willing to participate as evidenced by signing the informed consent
  • •Subject presenting at the site with normal eyes* (Cataracts and LASIK and PRK are allowed)
  • •BCVA 20/40 or better (each eye)
  • •Subject is able to comply with the study procedures in the view of the investigator *Normal eyes are defined as eyes judged normal for the subjects age as determined by the PI or sub-investigator

Exclusion Criteria

  • •Subject unable to tolerate ophthalmic imaging
  • •Subject with ocular media not sufficiently clear to obtain acceptable OCT images
  • •History of leukemia, dementia or multiple sclerosis

Arms & Interventions

Single

Other

Intervention: P200TE (Device)

Outcomes

Primary Outcomes

Retinal thickness

Time Frame: 1 day

In general, descriptive statistics (n, mean, standard deviation, median, minimum and maximum) and 95% confidence interval for the mean will be used to summarize each scan parameters. The 1st, 5th, 95th and 99th percentile results will be tabulated. All percentile results will be incorporated in the device software.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Optos, PLC
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (5)

Loading locations...

Similar Trials